Page last updated: 2024-08-17

carbostyril and Adenocystic Carcinoma

carbostyril has been researched along with Adenocystic Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dillon, PM; Douvas, MG; Fracasso, PM; Horton, BJ; Moskaluk, CA; Petroni, GR; Thomas, CY; Varhegyi, N; Zaja-Milatovic, S1
Bang, YJ; Cho, BC; Keam, B; Kim, MK; Kim, SB; Lee, KW; Lee, SH; Shin, SH; Yoon, DH; Yun, HJ1

Trials

2 trial(s) available for carbostyril and Adenocystic Carcinoma

ArticleYear
A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Aug-01, Volume: 23, Issue:15

    Topics: Adult; Aged; Benzimidazoles; Carcinoma, Adenoid Cystic; Cell Proliferation; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oncogene Proteins v-myb; Quinolones; Receptor, Fibroblast Growth Factor, Type 1

2017
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma.
    Cancer, 2015, Aug-01, Volume: 121, Issue:15

    Topics: Adult; Aged; Antineoplastic Agents; Benzimidazoles; Carcinoma, Adenoid Cystic; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Quinolones; Republic of Korea; Salivary Gland Neoplasms; Treatment Outcome; Young Adult

2015